Capital International Investors Horizon Therapeutics Public LTD CO Transaction History

Capital International Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $827 Million - $874 Million	-7,702,586 Reduced 82.78%	1,602,229 $175 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $42.6 Million - $77.6 Million	682,205 Added 7.91%	9,304,815 $1.06 Billion
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $56.4 Million - $81 Million	957,225 Added 12.49%	8,622,610 $534 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $46.8 Million - $68.6 Million	589,728 Added 8.33%	7,665,385 $611 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $611 Million - $777 Million	7,075,657 New	7,075,657 $744 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.